CP
TDOC icon

Corbenic Partners’s Teladoc Health TDOC Stock Holding History

Corbenic Partners’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$0 Sell
4
-200
-98% -$8.49K ﹤0.01% 241
2022
Q1 		$15K Sell
204
-163
-44% -$11.7K ﹤0.01% 128
2021
Q4 		$34K Buy
367
+113
+44% +$13.5K 0.01% 99
2021
Q3 		$32K Sell
254
-68
-21% -$9.9K 0.01% 97
2021
Q2 		$54K Buy
322
+104
+48% +$16.9K 0.01% 84
2021
Q1 		$40K Buy
218
+62
+40% +$14.4K 0.01% 94
2020
Q4 		$31K Buy
156
+90
+136% +$18.3K 0.01% 87
2020
Q3 		$14K Buy
+66
New +$14K 0.01% 102

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

Corbenic Partners's TDOC Position: Q2 2022 in Review

Corbenic Partners reduced its Teladoc Health (TDOC) stake by 98% in Q2 2022, selling an estimated $8.49K and leaving 4 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #241.

Corbenic Partners first reported a position in TDOC in Q3 2020 and has held it in 8 quarters since. The position peaked at $54K in Q2 2021. 550 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Corbenic Partners held 4 shares of Teladoc Health worth $0 as of Q2 2022.
  • Corbenic Partners sold 200 Teladoc Health shares in Q2 2022, an estimated $8.49K.
  • Teladoc Health made up ﹤0.01% of Corbenic Partners's portfolio in Q2 2022, its #241 holding.
  • Corbenic Partners first reported a position in Teladoc Health in Q3 2020 and has held it in 8 quarters since.
  • Corbenic Partners's Teladoc Health position peaked at $54K in Q2 2021.
  • 550 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Corbenic Partners's 13F filing for Q2 2022, filed 25 Jul 2022.